Literature DB >> 15657617

Cascade testing in familial hypercholesterolaemia: how should family members be contacted?

Ainsley J Newson1, Steve E Humphries.   

Abstract

Cascade testing or screening provides an important mechanism for identifying people at risk of a genetic condition. For some autosomal dominant conditions, such as familial hpercholesterolaemia (FH), identifying relatives allows for significant health-affecting interventions to be administered, which can extend a person's life expectancy significantly. However, cascade screening is not without ethical implications. In this paper, we examine one ethically contentious aspect of cascade screening programmes, namely the alternative methods by which relatives of a proband can be contacted. Should the proband be invited to contact his or her family members, or should the screening programme contact family members directly? We argue that direct contact is an ethically justifiable method of contact tracing in cascade screening for FH. Not only has this method already been utilised without adverse effects, an examination of the ethical arguments against it shows these are unsubstantiated. We describe several criteria that, if met, will allow an appropriate balance to be struck between maximising the efficiency of family tracing and respecting the interests of probands and their relatives.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  2005        PMID: 15657617     DOI: 10.1038/sj.ejhg.5201360

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  36 in total

Review 1.  How communication of genetic information within the family is addressed in genetic counselling: a systematic review of research evidence.

Authors:  Álvaro Mendes; Milena Paneque; Liliana Sousa; Angus Clarke; Jorge Sequeiros
Journal:  Eur J Hum Genet       Date:  2015-08-12       Impact factor: 4.246

2.  Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder.

Authors:  G K Suthers; J Armstrong; J McCormack; D Trott
Journal:  J Med Genet       Date:  2005-12-21       Impact factor: 6.318

Review 3.  Implications of data protection legislation for family history.

Authors:  Anneke Lucassen; Michael Parker; Robert Wheeler
Journal:  BMJ       Date:  2006-02-04

4.  Should families own genetic information? Yes.

Authors:  Anneke Lucassen
Journal:  BMJ       Date:  2007-07-07

Review 5.  Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology.

Authors:  Maya S Safarova; Iftikhar J Kullo
Journal:  Circ Res       Date:  2018-01-05       Impact factor: 17.367

Review 6.  Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.

Authors:  Frauke Becker; Carla G van El; Dolores Ibarreta; Eleni Zika; Stuart Hogarth; Pascal Borry; Anne Cambon-Thomsen; Jean Jacques Cassiman; Gerry Evers-Kiebooms; Shirley Hodgson; A Cécile J W Janssens; Helena Kaariainen; Michael Krawczak; Ulf Kristoffersson; Jan Lubinski; Christine Patch; Victor B Penchaszadeh; Andrew Read; Wolf Rogowski; Jorge Sequeiros; Lisbeth Tranebjaerg; Irene M van Langen; Helen Wallace; Ron Zimmern; Jörg Schmidtke; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2011-04       Impact factor: 4.246

7.  Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists.

Authors:  Fred H Menko; Cora M Aalfs; Lidewij Henneman; Yrrah Stol; Miranda Wijdenes; Ellen Otten; Marleen M J Ploegmakers; Johan Legemaate; Ellen M A Smets; Guido M W R de Wert; Aad Tibben
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

Review 8.  Communication and technology in genetic counseling for familial cancer.

Authors:  H T Lynch; C Snyder; M Stacey; B Olson; S K Peterson; S Buxbaum; T Shaw; P M Lynch
Journal:  Clin Genet       Date:  2013-12-20       Impact factor: 4.438

9.  Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.

Authors:  Melissa K Frey; Ryan M Kahn; Eloise Chapman-Davis; Francesca Tubito; Maira Pires; Paul Christos; Samantha Anderson; Semanti Mukherjee; Bailey Jordan; Stephanie V Blank; Thomas A Caputo; Ravi N Sharaf; Kenneth Offit; Kevin Holcomb; Steven Lipkin
Journal:  J Clin Oncol       Date:  2020-01-10       Impact factor: 44.544

10.  A novel approach to screening for familial hypercholesterolemia in a large public venue.

Authors:  Megan Campbell; Jessa Humanki; Heather Zierhut
Journal:  J Community Genet       Date:  2016-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.